Rezultati pretraživanja
  1. new Guidelines OA: 🥊exercise (aerobic/streng/neuroM/aquatic🏖) 🥝🥬🔽weigth🚫🍔🚫 ✅tai chi 🚫TENS🚫(no evidence) ✅topical/oral NDSAIDs/intraarticular GCs 🚫intraarticular HyA (hip)🚫 🚫glucosamine and/or chondroitin🚫 (Look slides 👁👁)

  2. 21. stu 2019.

    "Update in Myositis" session with tips on how to use the new classification criteria I honestly find them difficult and only reference in marginal cases Excellent tables from the presentation, though - great reference for antibodies and presentations!

  3. 1. velj

    Rt : Episode 7 of ACR on Air looks at a few more studies featured during our press conferences. Listen at:

  4. 28. sij

    ¿Conoces nuestros highlights del encuentro anual del American College of Rheumatology que se celebró en Atlanta? Visiona estos vídeos con el Dr. Jesús Tornero, Servicio de Hospital de Guadalajara 👉

  5. 28. sij

    Check our podcast on one of the highlights from : results of next promising new treatments in & with & Dr Atul Deodhar

  6. 16. pro 2019.

    Retrospective cohort study of 154 RA patients undergoing 244 major surgeries in shows that perioperative use of DMARDs (39%) or biologics (13%) was not associated with 30-day odds of post-operative infection Abst #1805

  7. Prikaži ovu nit
  8. 2. pro 2019.

    Management of GCA Guidelines from (FIXED!): The presenter went quickly by the slide on methotrexate & the slide deck was not available during the presentation. Small update now that slides are available, MTX recs included: "[MTX] can be considered as initial treatment"

  9. 24. stu 2019.

    This is the best summary of that I’ve seen. Great work putting this together and the rest of the community.

  10. 24. stu 2019.

    Excited to share this report of the big takeaways for patients, with lots of help from & others. Too much to pack into just one resource, so we have 6 wrap-up stories this year!

  11. 23. stu 2019.

    I missed this one during (found via 's weekly roundup): Abstract L19: Early study, but BAFF inhibitor Ianalumab met its primary endpoint in primary Sjogren's.

  12. 22. stu 2019.

    - Update in Myositis: Don't forget about toxin induced myopathy! Important mimickers related to treatment we give! 1. Steroid: myopathy w/o inflammation 2. Colchicine: vacuolar myopathy 3. Anti-malarial: vacuolar degeneration P.S. This might be good boards prep...

  13. spent several days in atlanta w/ my friends & colleagues & . it’s taken many years of advocacy to reach this moment. thank you for inviting patient advocates in such a meaningful way to author abstracts & present posters at

  14. 18. stu 2019.

    I wrote about being a first time patient at . What an amazing experience, I WILL go again! Thank you for sponsoring me! Thank you for being my mentor. Also thanks to those who came to see me speak!

  15. 16. stu 2019.

    Presenting our poster "Antisynthetase Syndromes: Correlation of IIFA Patterns with Diagnosis Criteria Fulfillment" at in Atlanta. Many thanks to , and for contributing to this project and its presentation at this meeting.

  16. 15. stu 2019.

    The gist: blood levels and thrombotic events in . Risk reduction may be 2-3 times higher than for aspirin in secondary prevention of vascular events. Need to define treat to target strategies.

  17. 14. stu 2019.

    ❓Can the happiest subspecialists experience burnout? 🌻 Now back from , I am rekindled with a new spark and inspiration thanks to each and every one of you! ⬇️ Please read my article for on burnout in rheumatology:

  18. 14. stu 2019.

    🔹Are you looking 🔎 for a visual summary 📑 of the main (and their 🎯 & ) for the 💊 of systemic presented at ? 🔹 Well...here it is!

  19. 14. stu 2019.

    Nouvelles recos sur la goutte au congrès ☑Crise: AINS ou colchicine petite dose ☑Hypouricémiant à introduire au moment de la crise (ça me fait bizarre d'écrire ça) ☑Pas d'hypouricémiant pour une uricémie haute sans crise ☑Allopurinol 1ere ligne (pour u<360umol/l)

  20. 13. stu 2019.

    Behcets - oral ulcers not NECESSARY for dx and 20% may present with uveitis. Revascularization not recommended for Takayasu as first line tx- get inflammation under control. Good skin biopsy needs fat to diagnose medium vessel vasculitis so go deep. Dr. West

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.